NeurogesX Reports Second Quarter 20...(NEUROGESX INC. ...)

Date:8/7/2009

NEUROGESX, INC. (A Development Stage Company) Condensed Consolidated Statements of Operations (in thousands, except share and per share data) (unaudited) Three Months Ended Six Months Ended June 30, June 30, ------------------ ---------------- 2009 2008 2009 2008 ---- ---- ---- ---- Operating expenses: Research and development(1) $2,780 $4,174 $5,106 $9,955 General and administrative(2) 2,605 2,863 4,794 5,350 ----- ----- ----- ----- Total operating expenses 5,385 7,037 9,900 15,305 ----- ----- ----- ------ Loss from operations (5,385) (7,037) (9,900) (15,305) Interest income 11 285 45 789 Interest expense (68) (214) (188) (457) Other income (expense), net 10 22 10 39 -- -- -- -- Net loss $(5,432) $(6,944) $(10,033) $(14,934) ======= ======= ======== ======== Basic and diluted net loss per share attributable to common stockholders $(0.31) $(0.40) $(0.57) $(0.85) ====== ====== ====== ====== Shares used to compute basic and diluted net loss per share attributable to
'/>"/>

SOURCE NeurogesX, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12
Related biology technology :

1. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
2. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
3. NeurogesX Added to Russell 3000 Index
4. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
5. NeurogesX to Present at Needham Life Sciences Conference
6. NeurogesX Receives European Commission Approval for Qutenza(TM)
7. NeurogesX Reports First Quarter 2009 Results
8. NeurogesX to Hold Conference Call to Discuss First Quarter 2009 Financial Results
9. NeurogesX Presents Two Posters at 61st Annual American Academy of Neurology Annual Meeting
10. NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Year-End 2008 Financial Results and European Regulatory Update
11. NeurogesX Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union